Blood-based biomarkers reflecting neuronal and astroglial injury, such as neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP), have been exploited in healthy subjects and a variety of neurological disorders including TBI [9–11]. The gene discussed is NEFL; the disease is nervous system disorder.